direct‐acting antivirals for the treatment of HCV during pregnancy and lactation‐implications for maternal dosing, foetal exposure, and safety for mother and child

JJM Freriksen, M van Seyen, A Judd… - Alimentary …, 2019 - Wiley Online Library
Background With the global efforts to eradicate hepatitis C virus (HCV), treatment during
pregnancy is becoming a priority for research as this, and maternal cure should reduce …

[HTML][HTML] Hepatitis C, a mega menace: a Pakistani perspective

M Umar, M Bilal - Journal of Pioneering Medical Sciences, 2012 - jpmsonline.com
About 10 million Pakistani population is infected with Hepatitis C virus (HCV). The
prevalence is even more pronounced among high risk population. The commonest mode of …

Highly sensitive and selective detection of melatonin in Biofluids by Antipyrine Based Fluorophore

S Vijayakumar, S Venkatesan, MC Lin… - Journal of …, 2023 - Springer
A simple fluorescent based organic fluorophore was synthesized and it shows significant
fluorescent intensity with melatonin (MLN). Hence, it was applicable to the detection of MLN …

[HTML][HTML] Hepatocellular carcinoma occurs frequently and early after treatment in HCV genotype 3 infected persons treated with DAA regimens

GUN Tayyab, S Rasool, B Nasir, G Rubi… - BMC …, 2020 - Springer
Background There are conflicting data regarding the risk of hepatocellular carcinoma (HCC)
after direct-acting antiviral agent (DAA) treatment. Risk of HCC in HCV genotype-3 infected …

[HTML][HTML] End treatment response and sustained viral response in patients with hepatitis C virus receiving sofosbuvir and daclatasvir

AS Rahman, M Amir, Q Jamal, M Riaz, K Fareed… - Cureus, 2023 - ncbi.nlm.nih.gov
Objective The main purpose of this study was to determine the end treatment response
(ETR) and sustained viral response (SVR) in hepatitis C virus (HCV) patients receiving …

Micro‐elimination of hepatitis C through testing of Egyptian pregnant women presenting at delivery: implications for screening policies

A Mostafa, FSE Ebeid, B Khaled… - Tropical Medicine & …, 2020 - Wiley Online Library
Objectives Despite the high burden of hepatitis C virus (HCV) infection in Egypt, screening of
pregnant women is not yet universal, making national and global elimination unlikely. This …

[HTML][HTML] Systematic review and meta-analysis: real-world effectiveness of direct-acting antiviral therapies in chronic hepatitis C genotype 3 in Asia

B Wei, F Ji, YH Yeo, E Ogawa… - BMJ open …, 2018 - bmjopengastro.bmj.com
Background Genotype 3 (GT3) is a common chronic hepatitis C (CHC) genotype in Asia.
Direct-acting antiviral (DAA) regimens have high cure rates, but real-world results are limited …

[HTML][HTML] Hepatitis C virus infection in pregnancy and children: its implications and treatment considerations with directly acting antivirals: a review

R Rana, R Dangal, Y Singh, RB Gurung… - JNMA: Journal of the …, 2021 - ncbi.nlm.nih.gov
Hepatitis C virus infection is a global health problem affecting> 71 million people worldwide
with chronic hepatitis C, 40% reproductive age group, and 8% pregnant women. Intravenous …

World Gastroenterology Organisation global guidelines: diagnosis, management and prevention of hepatitis C April 2013

M Umar, AG Khan, Z Abbas, S Arora… - Journal of Clinical …, 2014 - journals.lww.com
WGO GLOBAL PERSPECTIVE—RESOURCESENSITIVE GUIDELINES AND “CASCADES”
This guideline will be of interest to all health professionals in primary and secondary care …

[PDF][PDF] Efficacy and safety of generic daclatasvir+ sofosbuvir±ribavirin in treatment of genotype 3 infected hepatitis C patients-a real life experience from Pakistan

M Umar, TS Akhter, J Sadiq, S Saleem, S Khokhar - Hepatoma Res, 2018 - f.oaes.cc
Aim: Genotype 3 is the most prevalent genotype in Pakistan. Despite a revolution in the
treatment of Hepatitis C, genotype 3 is still thought to be difficult to treat genotype. The price …